Skip to main content
. 2014 Jul 29;6(6):144–153. doi: 10.5539/gjhs.v6n6p144

Table 5.

The comparison of the average of physical symptoms severity of premenstrual syndrome before and after treatment in students of the dormitories of Jahrom University in 2013

Treatment stage Vitamin B1 group Placebo group Result of test (Mann- Whitney)
Average of score + standard deviation Average of score + standard deviation
Before treatment 34.19 ± 0.72 35.27 ± 0.98 NS
After one month treatment 19.40 ± 0.63 33.51 ± 0.94 0.0001< P
After two months treatment 12.99 ± 0.63 30.51 ± 0.94 0.0001< P
The average of reduction of general severity of the symptoms after treatment 21.20 ± 0.63 4.76 ± 0.46 0.0001< P
Intra – group difference 0.0001< P 0.001< P
(Wilcoxon test)

The average physical symptoms severity of premenstrual syndrome has been reduced in Vitamin B1 group after treatment.